<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>GB-CHC-1099776-M1</iati-identifier>
  <reporting-org ref="GB-CHC-1099776" type="21" xml:lang="EN">
   <narrative xml:lang="EN">Malaria Consortium</narrative>
  </reporting-org>
  <title xml:lang="EN">
   <narrative xml:lang="EN">Improving Severe Malaria Outcomes</narrative>
  </title>
  <description type="1" xml:lang="EN">
   <narrative xml:lang="EN">This project aims to reduce severe malaria case fatality rates through improved access to and use of Injection Artesunate for the treatment severe malaria. A consortium of partners, comprising Medicines for Malaria Venture, Clinton Health Access Initiative, Partnership for Supply Chain Management and Malaria Consortium have developed this project to improve malaria outcomes through improving access to injection artesunate and intra rectal artesunate. The project will support the increase in uptake and use of injectable artesunate (Inj AS) and bring quality intra rectal artesunate to patients for pre-referral treatment of severe malaria. The consortium partners will undertake a series of coordinated, parallel market interventions addressing key barriers on both the supply and demand side of the market for Inj AS.</narrative>
  </description>
  <participating-org ref="GB-CHC-1099776" role="4" type="21" xml:lang="EN">
   <narrative xml:lang="EN">Malaria Consortium</narrative>
  </participating-org>
  <participating-org role="1" type="21" xml:lang="EN">
   <narrative xml:lang="EN">Medicines for Malaria Venture</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2013-06-05" type="2"></activity-date>
  <activity-date iso-date="2016-09-15" type="3"></activity-date>
  <activity-date iso-date="2016-09-15" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Malaria Consortium</narrative>
   </organisation>
   <person-name>
    <narrative xml:lang="EN">Malaria Consortium</narrative>
   </person-name>
   <email>iati@malariaconsortium.org</email>
   <mailing-address>
    <narrative xml:lang="EN">The Green House, 244-254 Cambridge Heath Road, London, E2 9DA, United Kingdom</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="ET" percentage="18"></recipient-country>
  <recipient-country code="NG" percentage="32"></recipient-country>
  <recipient-country code="UG" percentage="21"></recipient-country>
  <recipient-region code="298" percentage="29" vocabulary="1"></recipient-region>
  <sector code="12262" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Malaria control</narrative>
  </sector>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2013-06-05"></period-start>
   <period-end iso-date="2016-06-04"></period-end>
   <value currency="USD" value-date="2013-06-05">3205828</value>
  </budget>
  <budget type="2">
   <period-start iso-date="2013-06-05"></period-start>
   <period-end iso-date="2016-09-15"></period-end>
   <value currency="USD" value-date="2016-06-03">3242858</value>
  </budget>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2013-09-30"></transaction-date>
   <value currency="USD" value-date="2013-09-30">921529</value>
   <provider-org>
    <narrative xml:lang="EN">Medicines for Malaria Venture</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
   <flow-type code="10"></flow-type>
   <finance-type code="110"></finance-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2013-12-31"></transaction-date>
   <value currency="USD" value-date="2013-12-31">140790</value>
   <provider-org>
    <narrative xml:lang="EN">Medicines for Malaria Venture</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
   <flow-type code="10"></flow-type>
   <finance-type code="110"></finance-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2013-12-31"></transaction-date>
   <value currency="USD" value-date="2013-12-31">3205828</value>
   <provider-org>
    <narrative xml:lang="EN">Medicines for Malaria Venture</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
   <flow-type code="10"></flow-type>
   <finance-type code="110"></finance-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2014-07-14"></transaction-date>
   <value currency="USD" value-date="2014-07-14">1136298</value>
   <provider-org>
    <narrative xml:lang="EN">Medicines for Malaria Venture</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
   <flow-type code="10"></flow-type>
   <finance-type code="110"></finance-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2015-01-28"></transaction-date>
   <value currency="USD" value-date="2015-01-28">486889</value>
   <provider-org>
    <narrative xml:lang="EN">Medicines for Malaria Venture</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
   <flow-type code="10"></flow-type>
   <finance-type code="110"></finance-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2015-06-23"></transaction-date>
   <value currency="USD" value-date="2015-06-23">611286</value>
   <provider-org>
    <narrative xml:lang="EN">Medicines for Malaria Venture</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
   <flow-type code="10"></flow-type>
   <finance-type code="110"></finance-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2016-08-16"></transaction-date>
   <value currency="USD" value-date="2016-08-16">474445</value>
   <provider-org>
    <narrative xml:lang="EN">Medicines for Malaria Venture</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
   <flow-type code="10"></flow-type>
   <finance-type code="110"></finance-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2017-03-03"></transaction-date>
   <value currency="USD" value-date="2017-03-03">14962</value>
   <provider-org>
    <narrative xml:lang="EN">Medicines for Malaria Venture</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
   <flow-type code="10"></flow-type>
   <finance-type code="110"></finance-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <related-activity ref="GB-CHC-1099776-M1-298" type="2"></related-activity>
  <related-activity ref="GB-CHC-1099776-M1-ET" type="2"></related-activity>
  <related-activity ref="GB-CHC-1099776-M1-NG" type="2"></related-activity>
  <related-activity ref="GB-CHC-1099776-M1-UG" type="2"></related-activity>
 </iati-activity>
</iati-activities>
